Long-acting 2-adrenoceptor agonists: increased risk of death?

By  

Reactions Weekly, Vol. 1, Iss. 1072, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

In vivo characterization of novel full and partial 2-(4-aminophenyl)-N,N-dipropylethylamine dopamine D 2 receptor agonists 1

By Ahlenius S.   Ericson E.   Florvall L.   Jimenez P.   Hillegaart V.   Wijkstrom A.  

European Journal of Pharmacology, Vol. 394, Iss. 2, 2000-04 ,pp. : 247-253

Elsevier

Access to resources Recommend Favorite

In Vitro and Ex Vivo Characterization of Sigma-1 and Sigma-2 Receptors: Agonists and Antagonists in Biological Assays

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 3, 2009-09 ,pp. : 161-171

Bentham Science Publishers

Access to resources Recommend Favorite

Long-acting -agonists not linked to increased respiratory deaths

By  

Reactions Weekly, Vol. 1, Iss. 1202, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Gambling, increased libido: class effects of dopamine agonists

By  

Reactions Weekly, Vol. 1, Iss. 1128, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite